Check-Cap Ltd. (MBAI) - Total Liabilities
Based on the latest financial reports, Check-Cap Ltd. (MBAI) has total liabilities worth $4.05 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Check-Cap Ltd. (MBAI) cash flow conversion to assess how effectively this company generates cash.
Check-Cap Ltd. - Total Liabilities Trend (2021–2025)
This chart illustrates how Check-Cap Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Check MBAI asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Check-Cap Ltd. Competitors by Total Liabilities
The table below lists competitors of Check-Cap Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CBL International Limited Ordinary Shares
NASDAQ:BANL
|
USA | $39.56 Million |
|
pferdewetten.de AG
XETRA:EMH
|
Germany | €47.30 Million |
|
Admiralty Resources NL
AU:ADY
|
Australia | AU$18.25 Million |
|
AirIQ Inc
V:IQ
|
Canada | CA$1.09 Million |
|
Four Leaf Acquisition Corporation Class A Common Stock
NASDAQ:FORL
|
USA | $26.89 Million |
|
Sarama Resources Ltd
AU:SRR
|
Australia | AU$1.95 Million |
|
Bioatla Inc
NASDAQ:BCAB
|
USA | $47.15 Million |
|
i2S SA
PA:ALI2S
|
France | €6.67 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Check-Cap Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Check-Cap Ltd. (MBAI) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Check-Cap Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Check-Cap Ltd. (2021–2025)
The table below shows the annual total liabilities of Check-Cap Ltd. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $4.05 Million | +121.62% |
| 2024-12-31 | $1.83 Million | +37.37% |
| 2023-12-31 | $1.33 Million | -67.79% |
| 2022-12-31 | $4.13 Million | -16.89% |
| 2021-12-31 | $4.97 Million | -- |
About Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.